Allogene Therapeutics (ALLO) Tax Provisions (2018 - 2019)
Allogene Therapeutics' (ALLO) quarterly Tax Provisions came in at -$155000.0 in Q4 2019, down 32.48% year-on-year from -$229557.0 in Q4 2018, and down 569.7% quarter-over-quarter from $33000.0 in Q3 2019.
Allogene Therapeutics (ALLO) Tax Provisions (2018 - 2019) Analysis & Trends
Allogene Therapeutics has disclosed Tax Provisions across 2 years of filings, most recently posting -$155000.0 for Q4 2019.
- Tax Provisions for Q4 2019 came in at -$155000.0, down 32.48% year-over-year; the trailing twelve-month figure through Sep 2020 was -$155000.0 (up 53.59% YoY), and the FY2024 annual result was $443000.0, changed N/A from the prior year.
- Tax Provisions came in at -$155000.0 for Q4 2019 at Allogene Therapeutics, down from $33000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $33000.0 in Q3 2019 to a low of -$200000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Allogene Therapeutics | 482.98 Mn | 482.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -155,000.00 |
| Sep 30, 2019 | 33,000.00 |
| Jun 30, 2019 | -200,000.00 |
| Mar 31, 2019 | -50,000.00 |
| Dec 31, 2018 | -117,000.00 |